|
Clavubactin 50/12,5 mg tablet
|
-
|
V/NRP/08/1611
|
Le Vet B.V., Nīderlande
|
QJ01CR02
|
dogs; cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
tablets
|
| International name (active substance): |
Amoxicillin,Potassium clavulanate
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Lelypharma B.V., Nīderlande
|
| Date of authorisation/renewal: |
09-Jun-2014
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[PDF] 290514LI (09-Jun-2014)
|
| Labelling text: |
[PDF] 290514M (09-Jun-2014)
|
| Summary of product characteristics: |
[PDF] 290514ZA (09-Jun-2014)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/08/1611-01 |
50 mg/12,5 tabl. |
5 |
Alumīnija blisteris, 2 tablete |
-
|
| V/NRP/08/1611-02 |
50 mg/12,5 mg |
5 |
Alumīnija blisteris, 4 tablete |
-
|
| V/NRP/08/1611-03 |
50 mg/12,5 mg |
25 |
Alumīnija blisteris, 4 tablete |
-
|
| V/NRP/08/1611-04 |
50 mg/12,5 mg |
50 |
Alumīnija blisteris, 4 tablete |
-
|
| V/NRP/08/1611-05 |
50 mg/12,5 mg |
25 |
Alumīnija blisteris, 10 tablete |
-
|
| V/NRP/08/1611-06 |
50 mg/12,5 mg |
1 |
Alumīnija blisteris, 10 tablete |
-
|
| V/NRP/08/1611-07 |
50 mg/12,5 mg |
10 |
Alumīnija blisteris, 10 tablete |
-
|
| V/NRP/08/1611-08 |
50 mg/12,5 mg |
50 |
Alumīnija blisteris, 2 tablete |
-
|
|
|
Clavubactin 250/62,5 mg tablet
|
-
|
V/NRP/08/1612
|
Le Vet B.V., Nīderlande
|
QJ01CR02
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
tablets
|
| International name (active substance): |
Amoxicillin,Potassium clavulanate
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Lelypharma B.V., Nīderlande
|
| Date of authorisation/renewal: |
09-Jun-2014
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[PDF] 290514LI (09-Jun-2014)
|
| Labelling text: |
[PDF] 290514M (09-Jun-2014)
|
| Summary of product characteristics: |
[PDF] 290514ZA (09-Jun-2014)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/08/1612-01 |
250 mg/62,5 mg |
5 |
Alumīnija blisteris, 2 tablete |
-
|
| V/NRP/08/1612-02 |
250 mg/62,5 mg |
5 |
Alumīnija blisteris, 4 tablete |
-
|
| V/NRP/08/1612-03 |
250 mg/62,5 mg |
10 |
Alumīnija blisteris, 10 tablete |
-
|
| V/NRP/08/1612-05 |
250 mg/62,5 mg |
25 |
Alumīnija blisteris, 10 tablete |
-
|
| V/NRP/08/1612-06 |
250 mg/62,5 mg |
25 |
Alumīnija blisteris, 4 tablete |
-
|
| V/NRP/08/1612-07 |
250 mg/62,5 mg |
50 |
Alumīnija blisteris, 4 tablete |
-
|
| V/NRP/08/1612-08 |
250 mg/62,5 mg |
1 |
Alumīnija blisteris, 10 tablete |
-
|
| V/NRP/08/1612-09 |
250 mg/62,5 mg |
50 |
Alumīnija blisteris, 2 tablete |
-
|
|
|
Clavubactin 500/125 mg tablet
|
-
|
V/NRP/08/1613
|
Le Vet B.V., Nīderlande
|
QJ01CR02
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
tablets
|
| International name (active substance): |
Amoxicillin,Potassium clavulanate
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Lelypharma B.V., Nīderlande
|
| Date of authorisation/renewal: |
09-Jun-2014
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[PDF] 290514LI (09-Jun-2014)
|
| Labelling text: |
[PDF] 290514M (09-Jun-2014)
|
| Summary of product characteristics: |
[PDF] 290514ZA (09-Jun-2014)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/08/1613-01 |
500 mg/125 mg |
5 |
Alumīnija blisteris, 2 tablete |
-
|
| V/NRP/08/1613-02 |
500 mg/125 mg |
5 |
Alumīnija blisteris, 4 tablete |
-
|
| V/NRP/08/1613-03 |
500 mg/125 mg |
25 |
Alumīnija blisteris, 4 tablete |
-
|
| V/NRP/08/1613-04 |
500 mg/125 mg |
50 |
Alumīnija blisteris, 4 tablete |
-
|
| V/NRP/08/1613-05 |
500 mg/125 mg |
25 |
Alumīnija blisteris, 10 tablete |
-
|
| V/NRP/08/1613-06 |
500 mg/125 mg |
1 |
Alumīnija blisteris, 10 tablete |
-
|
| V/NRP/08/1613-07 |
500 mg/125 mg |
10 |
Alumīnija blisteris, 10 tablete |
-
|
| V/NRP/08/1613-08 |
500 mg/125 mg |
50 |
Alumīnija blisteris, 2 tablete |
-
|
|
|
Atiquine P50
|
500 mg/g
|
V/NRP/02/1530
|
Fatro S.p.A., Itālija
|
QJ01MB07
|
birds; fish
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
oral powder
|
| International name (active substance): |
Flumequine
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Fatro S.p.A., Itālija
|
| Date of authorisation/renewal: |
15-Jul-2008
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[PDF] 191015LI (21-Oct-2015)
|
| Labelling text: |
[PDF] 191015M (21-Oct-2015)
|
| Summary of product characteristics: |
[PDF] 191015ZA (21-Oct-2015)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/02/1530-01 |
500 mg/g |
1 |
Plastikāta konteiners, 1 kg |
-
|
|
|
Cevac Mass L
|
-
|
V/MRP/16/0006
|
Ceva-Phylaxia Veterinary Biologicals Co. Ltd., Ungārija
|
QI01AD07
|
chickens
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate for oculonasal suspension
|
| International name (active substance): |
Live, attenuated infectious bronchitis virus, Massachusetts B-48 strain
|
| Distribution category: |
To be used only by veterinary surgeon
|
| Manufacturer(s) responsible for batch release |
Ceva-Phylaxia Veterinary Biologicals Co. Ltd., Ungārija
|
| Date of authorisation/renewal: |
25-Feb-2021
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
MRP
|
| Package leaflet: |
[DOCX] 290617LI (25-Feb-2021)
|
| Labelling text: |
[DOCX] 290617M (25-Feb-2021)
|
| Summary of product characteristics: |
[DOCX] 290617ZA (25-Feb-2021)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/16/0006-01 |
|
1 |
Stikla flakons, 1000 deva |
-
|
| V/MRP/16/0006-02 |
|
1 |
Stikla flakons, 2500 deva |
-
|
| V/MRP/16/0006-03 |
|
1 |
Stikla flakons, 5000 deva |
-
|
| V/MRP/16/0006-04 |
|
10 |
Stikla flakons, 1000 deva |
-
|
| V/MRP/16/0006-05 |
|
10 |
Stikla flakons, 2500 deva |
-
|
| V/MRP/16/0006-06 |
|
10 |
Stikla flakons, 5000 deva |
-
|
| V/MRP/16/0006-07 |
|
20 |
Stikla flakons, 1000 deva |
-
|
| V/MRP/16/0006-08 |
|
20 |
Stikla flakons, 2500 deva |
-
|
| V/MRP/16/0006-09 |
|
20 |
Stikla flakons, 5000 deva |
-
|
|
|
LV Macrolan WS
|
1000 mg/g
|
V/NRP/15/0023
|
Interchemie Werken De Adelaar Eesti AS, Igaunija
|
QJ01FA90
|
kids; pigs; turkeys; calves; lambs; chickens
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
powder for use in drinking water
|
| International name (active substance): |
Tylosin tartrate
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Interchemie Werken De Adelaar Eesti AS, Igaunija
|
| Date of authorisation/renewal: |
01-Jul-2020
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[DOCX] 01072020LI (01-Jul-2020)
|
| Labelling text: |
[DOCX] 01072020M (01-Jul-2020)
|
| Summary of product characteristics: |
[DOCX] 01072020ZA (01-Jul-2020)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/15/0023-01 |
1000 mg/g |
1 |
ABPE pudele, 500 g |
-
|
| V/NRP/15/0023-02 |
1000 mg/g |
1 |
Pudele, 1000 g |
-
|
| V/NRP/15/0023-03 |
1000 mg/g |
1 |
Folijas paciņa, 100 g |
-
|
|
|
Doxylin 100%
|
-
|
V/MRP/13/0053
|
Dopharma Research B.V., Nīderlande
|
QJ01AA02
|
pigs; calves
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/13/0053-01 |
1000 mg/g |
1 |
Polipropilēna konteiners, 1 kg |
-
|
| V/MRP/13/0053-02 |
1000 mg/g |
1 |
Polietilēna spainis, 1 kg |
-
|
| V/MRP/13/0053-03 |
1000 mg/g |
1 |
Polietilēna spainis, 2 kg |
-
|
| V/MRP/13/0053-04 |
1000 mg/g |
1 |
Polietilēna spainis, 5 kg |
-
|
| V/MRP/13/0053-05 |
1000 mg/g |
1 |
Polipropilēna konteiners, 100 g |
-
|
|
|
Avinew NEO
|
-
|
V/NRP/16/0003
|
Boehringer Ingelheim Animal Health France SCS , Francija
|
QI01AD06
|
chickens
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
effervescent tablets for suspension
|
| International name (active substance): |
Live Newcastle Disease virus, strain VG/GA-AVINEW
|
| Distribution category: |
To be used only by veterinary surgeon
|
| Manufacturer(s) responsible for batch release |
Boehringer Ingelheim Animal Health France SCS, Francija
|
| Date of authorisation/renewal: |
27-Oct-2020
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[DOCX] 271020_LI (27-Oct-2020)
|
| Labelling text: |
[DOCX] 271020_M (27-Oct-2020)
|
| Summary of product characteristics: |
[DOCX] 271020_ZA (27-Oct-2020)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/16/0003-01 |
|
10 |
Blisteris, 1000 deva |
-
|
| V/NRP/16/0003-02 |
|
100 |
Blisteris, 1000 deva |
-
|
| V/NRP/16/0003-03 |
|
10 |
Blisteris, 2000 deva |
-
|
| V/NRP/16/0003-04 |
|
100 |
Blisteris, 2000 deva |
-
|
|
|
Biocan Novel DHPPi
|
-
|
V/DCP/14/0049
|
Bioveta, a.s., Čehija
|
QI07AD04
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate and solvent for suspension for injection
|
| International name (active substance): |
Canine Parainfluenza virus, strain CPiV2-Bio15, Canine Adenovirus Type 2, strain CAV2-Bio 13, Canine Parvovirus Type 2, strain CPV-2b-Bio 12/B, Canine Distemper virus, strain CDV Bio 11/A
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Bioveta, a.s., Čehija
|
| Date of authorisation/renewal: |
30-Sep-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
[PDF] Skat_sadaļā_Zāļu_apraksts (24-Mar-2026)
|
| Labelling text: |
[PDF] Skat_sadaļā_Zāļu_apraksts (24-Mar-2026)
|
| Summary of product characteristics: |
[DOCX] Zāļu_informācija_ZA_M_LI (24-Mar-2026)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/14/0049-01 |
|
10 |
Stikla flakons, 1 deva |
[PDF]
[PDF]
[PDF]
|
| V/DCP/14/0049-02 |
|
25 |
Stikla flakons, 1 deva |
-
|
| V/DCP/14/0049-03 |
|
50 |
Stikla flakons, 1 deva |
-
|
|
|
Cortico Veyxin
|
10 mg/ml
|
V/DCP/18/0046
|
Veyx-Pharma GmbH, Vācija
|
QH02AB06
|
cattle; horses; dogs; cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
Prednisolone acetate
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Veyx-Pharma GmbH, Vācija
|
| Date of authorisation/renewal: |
28-Jan-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
[PDF] 021018LI (02-Oct-2018)
|
| Labelling text: |
[PDF] 021018M (02-Oct-2018)
|
| Summary of product characteristics: |
[PDF] 021018ZA (02-Oct-2018)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/18/0046-01 |
10 mg/ml |
1 |
Stikla flakons, 100 ml |
-
|
| V/DCP/18/0046-02 |
10 mg/ml |
6 |
Stikla flakons, 100 ml |
-
|
| V/DCP/18/0046-03 |
10 mg/ml |
12 |
Stikla flakons, 100 ml |
-
|
|
|
Rispoval IBR-Marker Vivum
|
-
|
V/MRP/08/1584
|
Zoetis Belgium S.A., Beļģija
|
QI02AD01
|
cattle
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/08/1584-02 |
|
1 |
Stikla pudelīte, 10 deva |
-
|
| V/MRP/08/1584-03 |
|
1 |
Stikla pudelīte, 50 deva |
-
|
|
|
Versifel CVR
|
-
|
V/NRP/10/0014
|
Zoetis Belgium S.A., Beļģija
|
QI06AD04
|
cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate and solvent for solution for injection
|
| International name (active substance): |
Live, attenuated feline calici virus,Feline rhinotracheitis virus,Attenuated feline panleucopenia virus
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Zoetis Belgium S.A., Beļģija
|
| Date of authorisation/renewal: |
22-Dec-2014
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[PDF] Skat_sadaļā_Zāļu_apraksts (19-Oct-2023)
|
| Labelling text: |
[PDF] Skat_sadaļā_Zāļu_apraksts (19-Oct-2023)
|
| Summary of product characteristics: |
[DOCX] Zāļu_informācija_ZA_M_LI (19-Oct-2023)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/10/0014-01 |
|
10 |
Stikla flakons, 1 deva |
-
|
| V/NRP/10/0014-02 |
|
25 |
Stikla flakons, 1 deva |
-
|
| V/NRP/10/0014-03 |
|
100 |
Stikla flakons, 1 deva |
-
|
|
|
Pen & Strep
|
-
|
V/NRP/96/0445
|
Norbrook Laboratories (Ireland) Limited, Īrija
|
QJ01RA01
|
cattle; pigs; sheep; horses
|
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
Procainpenicillin, Dihydrostreptomycin sulphate
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Norbrook Laboratories Limited, Lielbritānija;Norbrook Manufacturing Limited, Īrija
|
| Date of authorisation/renewal: |
14-Aug-2012
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[PDF] Skat_sadaļā_Zāļu_apraksts (05-Jan-2026)
|
| Labelling text: |
[PDF] Skat_sadaļā_Zāļu_apraksts (05-Jan-2026)
|
| Summary of product characteristics: |
[DOCX] Zāļu_informācija_ZA_M_LI (05-Jan-2026)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/96/0445-01 |
|
1 |
Stikla flakons, 50 ml |
-
|
| V/NRP/96/0445-02 |
|
1 |
Stikla flakons, 100 ml |
-
|
|
|
Sporimune
|
50 mg/ml
|
V/DCP/14/0041
|
Le Vet Beheer B.V., Nīderlande
|
QL04AD01
|
dogs; cats
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/14/0041-01 |
50 mg/ml |
1 |
Stikla pudele (brūna), 25 ml |
-
|
| V/DCP/14/0041-02 |
50 mg/ml |
1 |
Stikla pudele (brūna), 50 ml |
-
|
| V/DCP/14/0041-03 |
50 mg/ml |
1 |
Stikla pudele (brūna), 100 ml |
-
|
|
|
Novasul
|
500 mg/ml
|
V/NRP/97/0557
|
VetViva Richter GmbH , Austrija
|
QN02BB02
|
cattle; pigs; horses; dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Metamizole sodium monohydrate
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
VetViva Richter GmbH , Austrija
|
| Date of authorisation/renewal: |
20-May-2013
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[DOCX] 10052023_LI (10-May-2023)
|
| Labelling text: |
[DOCX] 23012023_M (23-Jan-2023)
|
| Summary of product characteristics: |
[DOCX] 23012023_ZA (23-Jan-2023)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/97/0557-01 |
500 mg/ml |
1 |
Stikla pudelīte (brūna), 100 ml |
-
|
|
|
Bimectin
|
18.7 mg/g
|
V/NRP/04/1631
|
Bimeda Animal Health Limited, Īrija
|
QP54AA01
|
horses
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/04/1631-01 |
18,7 mg/g |
1 |
Šļirce, 6,42 g |
-
|
|
|
Carpcoat
|
8 mg
|
V/DCP/25/0065
|
Alfasan Nederland BV, Nīderlande
|
QM01AE91
|
dogs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/25/0065-01 |
|
1 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/25/0065-02 |
|
2 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/25/0065-03 |
|
3 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/25/0065-04 |
|
4 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/25/0065-05 |
|
5 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/25/0065-06 |
|
6 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/25/0065-07 |
|
7 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/25/0065-08 |
|
8 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/25/0065-09 |
|
9 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/25/0065-10 |
|
10 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/25/0065-11 |
|
12 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/25/0065-12 |
|
25 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
|
|
Carpcoat
|
20 mg
|
V/DCP/25/0066
|
Alfasan Nederland BV, Nīderlande
|
QM01AE91
|
dogs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/25/0066-01 |
|
1 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/25/0066-02 |
|
2 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/25/0066-03 |
|
3 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/25/0066-04 |
|
4 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/25/0066-05 |
|
5 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/25/0066-06 |
|
6 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/25/0066-07 |
|
7 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/25/0066-08 |
|
8 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/25/0066-09 |
|
9 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/25/0066-10 |
|
10 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/25/0066-11 |
|
12 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/25/0066-12 |
|
25 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
|
|
Carpcoat
|
40 mg
|
V/DCP/25/0067
|
Alfasan Nederland BV, Nīderlande
|
QM01AE91
|
dogs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/25/0067-01 |
|
1 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/25/0067-02 |
|
2 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/25/0067-03 |
|
3 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/25/0067-04 |
|
4 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/25/0067-05 |
|
5 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/25/0067-06 |
|
6 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/25/0067-07 |
|
7 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/25/0067-08 |
|
8 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/25/0067-09 |
|
9 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/25/0067-10 |
|
10 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/25/0067-11 |
|
12 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/25/0067-12 |
|
25 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
|
|
Carpcoat
|
80 mg
|
V/DCP/25/0068
|
Alfasan Nederland BV, Nīderlande
|
QM01AE91
|
dogs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/25/0068-01 |
|
1 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/25/0068-02 |
|
2 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/25/0068-03 |
|
3 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/25/0068-04 |
|
4 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/25/0068-05 |
|
5 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/25/0068-06 |
|
6 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/25/0068-07 |
|
7 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/25/0068-08 |
|
8 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/25/0068-09 |
|
9 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/25/0068-10 |
|
10 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/25/0068-11 |
|
12 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/25/0068-12 |
|
25 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
|